Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1951 1
1952 2
1954 1
1957 1
1958 2
1959 1
1960 1
1961 1
1962 1
1963 2
1967 1
1968 4
1970 3
1971 5
1972 4
1973 4
1974 14
1975 7
1976 6
1977 8
1978 8
1979 6
1980 10
1981 8
1982 3
1983 8
1984 14
1985 14
1986 11
1987 17
1988 18
1989 12
1990 18
1991 10
1992 15
1993 19
1994 19
1995 24
1996 21
1997 26
1998 30
1999 28
2000 33
2001 21
2002 21
2003 26
2004 31
2005 31
2006 27
2007 28
2008 24
2009 30
2010 40
2011 25
2012 23
2013 22
2014 18
2015 18
2016 25
2017 20
2018 33
2019 29
2020 39
2021 45
2022 33
2023 34
2024 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,028 results

Results by year

Filters applied: . Clear all
Page 1
Biopharmaceutical benchmarks 2022.
Walsh G, Walsh E. Walsh G, et al. Nat Biotechnol. 2022 Dec;40(12):1722-1760. doi: 10.1038/s41587-022-01582-x. Nat Biotechnol. 2022. PMID: 36471135 Free PMC article.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Cascone T, William WN Jr, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G Jr, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Cascone T, et al. Among authors: walsh gl. Nat Med. 2021 Mar;27(3):504-514. doi: 10.1038/s41591-020-01224-2. Epub 2021 Feb 18. Nat Med. 2021. PMID: 33603241 Free PMC article. Clinical Trial.
Autophagy and Asthma.
Farooq MB, Walsh GM. Farooq MB, et al. Among authors: walsh gm. Clin Exp Allergy. 2016 Jan;46(1):7-9. doi: 10.1111/cea.12633. Clin Exp Allergy. 2016. PMID: 26767491 No abstract available.
Second-generation biopharmaceuticals.
Walsh G. Walsh G. Eur J Pharm Biopharm. 2004 Sep;58(2):185-96. doi: 10.1016/j.ejpb.2004.03.012. Eur J Pharm Biopharm. 2004. PMID: 15296948 Review.
Biopharmaceutical benchmarks 2018.
Walsh G. Walsh G. Nat Biotechnol. 2018 Dec 6;36(12):1136-1145. doi: 10.1038/nbt.4305. Nat Biotechnol. 2018. PMID: 30520869 No abstract available.
Levocetirizine: an update.
Walsh GM. Walsh GM. Curr Med Chem. 2006;13(22):2711-5. doi: 10.2174/092986706778201594. Curr Med Chem. 2006. PMID: 17017922 Review.
Biopharmaceutical benchmarks.
Walsh G. Walsh G. Nat Biotechnol. 2000 Aug;18(8):831-3. doi: 10.1038/78720. Nat Biotechnol. 2000. PMID: 10932150 No abstract available.
Biopharmaceutical benchmarks--2003.
Walsh G. Walsh G. Nat Biotechnol. 2003 Aug;21(8):865-70. doi: 10.1038/nbt0803-865. Nat Biotechnol. 2003. PMID: 12894198 No abstract available.
Anti-IL-4/-13 based therapy in asthma.
Walsh GM. Walsh GM. Expert Opin Emerg Drugs. 2015 Sep;20(3):349-52. doi: 10.1517/14728214.2015.1050377. Epub 2015 Jun 1. Expert Opin Emerg Drugs. 2015. PMID: 26021492 Review.
Surgical therapy of ground-glass opacities.
Sepesi B, Walsh GL. Sepesi B, et al. Among authors: walsh gl. Semin Diagn Pathol. 2014 Jul;31(4):289-92. doi: 10.1053/j.semdp.2014.06.006. Epub 2014 Jun 12. Semin Diagn Pathol. 2014. PMID: 25239273 Review.
1,028 results